Literature DB >> 11897451

Early and late complications associated with transcatheter occlusion of secundum atrial septal defect.

Massimo Chessa1, Mario Carminati, Gianfranco Butera, Roberta Margherita Bini, Manuela Drago, Luca Rosti, Alessandro Giamberti, Giuseppe Pomè, Eduardo Bossone, Alessandro Frigiola.   

Abstract

OBJECTIVES: The goal of this study was to report the early and late complications experienced in atrial septal defect (ASD) transcatheter closure.
BACKGROUND: Atrial septal defect transcatheter occlusion techniques have become an alternative to surgical procedures. A number of different devices are available for transcatheter ASD closure. The type and rate of complications are different for different devices.
METHODS: Between December 1996 and January 2001, 417 patients (mean age: 26.6 +/- 19 years) underwent transcatheter occlusion of secundum type ASD. Complications were categorized into major and minor. Two different devices were used: the CardioSEAL/STARFlex in 159 patients and the Amplatzer septal occluder in 258 patients.
RESULTS: Thirty-four patients experienced 36 complications during the hospitalization (8.6%, 95% confidence interval: 6.1% to 11.1%). Ten patients underwent elective surgical repair because of device malposition (three patients) or device embolization (seven patients). Twenty-four patients experienced 25 minor complications: unsatisfactory device position or embolization. Devices were retrieved using a gooseneck snare and/or a basket; 11 patients experienced arrhythmic problems. Other complications were: pericardial effusion, thrombus formation on the left atrial disc, right iliac vein dissection, groin hematoma, hemorrhage in the retropharynx and sizing balloon rupture. Two patients had late complications: peripheral embolization in the left leg one year after implantation of an Amplatzer device and sudden death 1.5 year later.
CONCLUSIONS: Our series of patients with ASD by transcatheter occlusion shows that the procedure is safe and effective in the vast majority of cases. To further reduce the complications rate, the criteria of device selection according to ASD morphology and some technical tips during implantation are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897451     DOI: 10.1016/s0735-1097(02)01711-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  129 in total

1.  Amplatzer septal occluder closure of secundum atrial septal defects in the presence of persistent left superior vena cava to coronary sinus.

Authors:  K M Carlson; T A Johnston; T K Jones; R G Grifka
Journal:  Pediatr Cardiol       Date:  2004 Nov-Dec       Impact factor: 1.655

2.  Amplatzer device closure of atrial septal defects in mature adults: analysis of 76 cases.

Authors:  D J R Hildick-Smith; M O'Sullivan; C R Wisbey; J H Mackay; E M Lee; L M Shapiro
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 3.  Closing down: transcatheter closure of intracardiac defects and vessel embolisations.

Authors:  Jean-François Piéchaud
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

4.  Inflammatory pseudothrombus on a patent foramen ovale occluder device.

Authors:  Stephen MacKerrow; Andrew Farb; Roberta Sullivan
Journal:  Tex Heart Inst J       Date:  2011

5.  Use of a novel hybrid approach to salvage an attempted transcatheter pulmonary valve implant.

Authors:  Darren P Berman; Redmond Burke; Evan M Zahn
Journal:  Pediatr Cardiol       Date:  2012-06       Impact factor: 1.655

Review 6.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

7.  Transthoracic echocardiographic guidance during transcatheter closure of atrial septal defects in children and adults.

Authors:  Abdullah Erdem; Turkay Sarıtas; Cenap Zeybek; Ilker Kemal Yucel; Nurdan Erol; Halil Demır; Ender Odemıs; Yalim Yalcın; Ahmet Celebı
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-11       Impact factor: 2.357

8.  Cribriform amplatzer device closure of fenestrated atrial septal defects: feasibility and technical aspects.

Authors:  Mohammed Numan; Amal El Sisi; Magdi Tofeig; Salwa Gendi; Tohami Tohami; Howaida G El-Said
Journal:  Pediatr Cardiol       Date:  2007-11-13       Impact factor: 1.655

Review 9.  [Echocardiography during transcatheter interventions. New developments].

Authors:  J Balzer
Journal:  Herz       Date:  2013-02       Impact factor: 1.443

10.  Successful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect occluder with abciximab and heparin.

Authors:  F E Willcoxson; J D R Thomson; J L Gibbs
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.